U.S. Stock News

NasdaqGS:KRNY
NasdaqGS:KRNYBanks

US Interest Rate Sensitive Financial Stocks Facing A New Test From Lower Treasury Yields

With Treasury yields easing after a rare expansion of US long term debt buybacks and inflation still above the Fed’s comfort zone, interest rate sensitive stocks are back in focus. These cross currents can quickly reprice expectations for banks, mortgage REITs and housing lenders, which creates both opportunity and risk for anyone watching this corner of the market. This article explains how three stocks exposed to the latest rate moves may either benefit or face fresh questions. The three...
NYSE:GSL
NYSE:GSLShipping

3 Dividend Fortresses For Passive Income As Bond Yields Hit Multi Month Highs

Government bond yields in the US and Europe have climbed to multi month highs, which puts fresh pressure on growth stocks and income seekers who rely on bonds. That shift pulls attention back to solid dividend payers. High yield Dividend Fortresses that offer 5%+ yields and resilient cash generation can look especially appealing. This article highlights three such stocks that aim to prioritise income and staying power. The three Dividend Fortresses in this article are just a starting sample,...
NasdaqGS:MSTR
NasdaqGS:MSTRSoftware

Is Strategy (MSTR) A Bargain As Bitcoin Buying Pauses And Capital Focus Shifts?

Strategy (MSTR) has paused new Bitcoin purchases for several weeks and raised more than US$333 million through common stock sales. Investors are now watching how this capital management shift affects credit stability and equity risk. See our latest analysis for Strategy. Over the past year Strategy’s share price has come under pressure, with a year to date share price return down 41.13% and a 1 year total shareholder return down 73.13%. In contrast, the 3 year total shareholder return is up...
NasdaqGS:TTWO
NasdaqGS:TTWOEntertainment

Take Two Interactive Software (TTWO) Could Be 13% Undervalued After Q1 Results And Guidance

Take-Two Interactive Software (TTWO) is drawing fresh attention after its 7 August 2026 first quarter results and updated guidance. Investors are weighing ongoing losses against management’s outlook for higher full year revenue and a return to profitability. See our latest analysis for Take-Two Interactive Software. The latest guidance has kept Take-Two Interactive Software in focus, with the share price at US$242.40 and shorter term share price returns more muted, while the 3 year total...
NasdaqGS:COLB
NasdaqGS:COLBBanks

Will Dividend Hike and Salt Lake City Expansion Change Columbia Banking System's (COLB) Narrative

Columbia Banking System previously declared a quarterly cash dividend of US$0.37 per common share, payable on September 14, 2026 to shareholders of record on August 28, 2026, and Columbia Bank has opened a new commercial office and retail branch in Draper, Utah as the first of three planned Salt Lake City-area locations for 2026. This combination of continued cash returns to shareholders and physical expansion into the Salt Lake City Metropolitan Area highlights Columbia’s focus on both...
NasdaqCM:HYMC
NasdaqCM:HYMCMetals and Mining

Does Hycroft Mining (HYMC) Have a Game-Changing Feeder System Emerging at Brimstone?

Hycroft Mining Holding Corporation recently reported additional drill results from its 2025–2026 exploration program at the Hycroft Mine in Nevada, highlighting thick high-grade silver and gold intercepts at the Brimstone and Vortex zones that remain open in all directions. Beyond confirming wide zones of high-grade mineralization, the results point to a potential feeder system at depth, which could materially influence how the deposit is ultimately mined. We’ll now examine how the...
NYSE:OUT
NYSE:OUTSpecialized REITs

OUTFRONT Media (OUT) Earnings And Jets Deal Put Valuation Back In Focus

OUTFRONT Media (OUT) has drawn fresh attention after a packed August 5 update that combined stronger year-over-year earnings, a higher quarterly dividend and a new multi-year partnership with the New York Jets. See our latest analysis for OUTFRONT Media. OUTFRONT Media’s share price has pulled back recently, with a 30 day share price return that declined 9.7% and a 90 day share price return that declined 8.7%. However, the year to date share price return of 26.4% and 1 year total shareholder...
NYSE:MUR
NYSE:MUROil and Gas

The Bull Case For Murphy Oil (MUR) Could Change Following Strong Q2 Earnings And Capital Returns

Murphy Oil Corporation recently reported past second-quarter 2026 results showing revenue of US$928.31 million and net income of US$232.18 million, with basic earnings per share from continuing operations of US$1.62, all higher than the same period in 2025. Alongside this earnings strength, Murphy Oil confirmed 2026 production guidance, maintained its US$0.35 quarterly dividend, and completed a near-10% share repurchase program, underscoring a continued focus on returning cash to...
NYSE:CDE
NYSE:CDEMetals and Mining

Coeur Mining (CDE) Record Gold Output Puts Fair Value Back In Focus

Coeur Mining (CDE) drew fresh attention after reporting record second quarter gold production of 163,490 ounces, alongside higher sales and net income, and issuing updated full year 2026 production guidance. See our latest analysis for Coeur Mining. Despite a dip of about 4% in the latest session to a share price of $18.51, Coeur Mining has seen strong momentum build, with a 29% 1 month share price return and a very large 3 year total shareholder return that reflects how investors have...
NYSE:ELV
NYSE:ELVHealthcare

Elevance Health (ELV) Could Be 11% Below Fair Value As Carelon Growth Draws Focus

Recent share performance and business scale With no single headline event driving market attention, Elevance Health (ELV) has drawn interest through its recent share performance and scale. The stock closed at $398.27, giving the company a market value near $84.6b. See our latest analysis for Elevance Health. Recent price action for Elevance Health points to building momentum, with a 1 month share price return of 6.74% and a year to date share price return of 12.43%. The 1 year total...
NasdaqCM:VKTX
NasdaqCM:VKTXBiotechs

Viking Therapeutics (VKTX) Stock Still Looks Pricey With Pipeline Hopes Priced In

Viking Therapeutics has delivered a very large 463.7% return over the past five years, yet the stock currently screens as expensive on the valuation checks, which raises questions about how much optimism is already in the price. Over five years, Viking Therapeutics has returned 463.7%, which signals investors have already paid up heavily for the growth story. Expectations for future revenue and cash flow from Viking Therapeutics' pipeline can support a premium, although any delay in turning...
NYSE:SSB
NYSE:SSBBanks

SouthState’s New Government Contractor Banking Push Might Change The Case For Investing In SSB

SouthState Bank recently expanded into Government Contractor Banking, appointing veteran banker and former MartinFederal Consulting CEO David Mathis to lead the new vertical and support clients with financing, treasury management, capital markets, and mergers and acquisitions services. This move introduces a specialized focus on the government contracting sector, pairing niche industry knowledge with commercial banking capabilities to broaden SouthState’s business banking offering. We’ll now...
NYSE:NWN
NYSE:NWNGas Utilities

Northwest Natural Holding (NWN) Guides To Upper Half Of EPS Range, Is It Still 11% Undervalued?

Northwest Natural Holding (NWN) stock is in focus after the company reported second quarter 2026 results, swung to a small net profit, and guided full year earnings per share toward the upper half of its 2026 range. See our latest analysis for Northwest Natural Holding. Northwest Natural Holding shares have edged higher in recent months, with a 90 day share price return of 2.2% and a year to date share price return of 9.16%. The 1 year total shareholder return of 30.75% and 3 year total...
NasdaqGS:DDOG
NasdaqGS:DDOGSoftware

Is Datadog (DDOG) Fairly Valued Following Its FedRAMP High Win And Vertosoft Partnership?

Datadog (DDOG) is drawing fresh attention after securing FedRAMP High certification for Datadog for Government and partnering with Vertosoft, a move that points directly to the US public sector opportunity. See our latest analysis for Datadog. Set against these government wins, Datadog’s share price has had a mixed few weeks, with a 30 day share price return down 4.9%, a 90 day share price return of 15.9%, and a 1 year total shareholder return of 90.7%. This points to momentum that has built...
NasdaqGM:RLAY
NasdaqGM:RLAYBiotechs

Relay Therapeutics (RLAY) Stock May Be Fully Valued After A 7x Run

Relay Therapeutics has delivered a very large 1 year return, yet the stock currently screens as expensive on broad valuation checks, which raises questions about how much optimism is already in the price. Relay Therapeutics has returned roughly 7x over the past 12 months, which puts unusual weight on whether the fundamentals can justify that kind of move. Expectations for future drug development and potential revenue can support the current valuation, while uncertainty around clinical...
NasdaqGS:PTCT
NasdaqGS:PTCTBiotechs

The Bull Case For PTC Therapeutics (PTCT) Could Change Following Renal Data Progress For ST-920

PTC Therapeutics recently held a special call to discuss the past regulatory progress of ST-920, whose Biologics License Application is supported by 52-week Phase 1/2 STAAR data showing meaningful renal benefit alongside a favorable safety and tolerability profile. This focus on ST-920’s clinical and regulatory trajectory highlights PTC’s deepening commitment to rare disease gene therapies and potential portfolio diversification beyond its current commercial base. We’ll now examine how...
NYSE:CW
NYSE:CWAerospace & Defense

Curtiss Wright (CW) Expands Buyback Program, Is The Stock Still Below Fair Value?

Curtiss-Wright (CW) extended its share repurchase activity on August 10, 2026, adding US$100 million to its buyback authorization and bringing the total program size to US$2.166 billion. See our latest analysis for Curtiss-Wright. Curtiss-Wright’s latest buyback expansion comes after a brief period of share price softness, with the stock down over the past quarter but still showing strong year to date share price returns and very strong multi year total shareholder returns. If this kind of...
NYSE:KMI
NYSE:KMIOil and Gas

Kinder Morgan (KMI) Stock Looks Like A Bargain On Cash Flow, Fair On Earnings

Kinder Morgan stock has delivered strong returns over the past few years, yet the current price near US$32.87 is still below an intrinsic value estimate from a Discounted Cash Flow (DCF) approach that points to roughly 40.4% upside. At the same time, market multiples suggest Kinder Morgan is trading at about the right level overall, which creates a mixed read on how much value is really left in the share price today. Over the past 5 years Kinder Morgan has returned about 161.3%, which puts...
NYSE:XYZ
NYSE:XYZDiversified Financial

Block (SQ) Stock Still Looks Undervalued Despite Its 71% Five Year Fall

Block stock is caught between two different valuation signals. The Excess Returns intrinsic value estimate points to meaningful upside from the current US$79.43 share price, while earnings based multiples flag the stock as expensive compared with its fundamentals. Block has declined 70.6% over the past 5 years, which leaves long term holders with a weak result and makes today’s entry point more sensitive to valuation. Recent AI driven restructuring and product rollout can support margin and...
NasdaqGM:HROW
NasdaqGM:HROWPharmaceuticals

Harrow (HROW) Reaffirms 2026 Guidance, Is The Upside Already Priced In?

Event recap and why Harrow stock is in focus Harrow (HROW) is back on investor radar after the company reiterated its 2026 revenue guidance of US$350 million to US$365 million and reported second quarter results that paired higher sales with a wider net loss. The stock has risen over the past 3 months but is down over the past month. That backdrop makes the latest guidance and earnings release an important checkpoint for anyone tracking Harrow’s eyecare focused plans. See our latest analysis...
NYSE:STE
NYSE:STEMedical Equipment

Should STERIS’ (STE) Record Chemistries Investment and Reaffirmed Outlook Require Action From Investors?

In early August 2026, STERIS plc reported first-quarter fiscal 2027 results showing higher sales of US$1,492.7 million and increased earnings, reiterated its full-year revenue growth guidance of 7% to 8%, appointed Pierre Boulud to key board committees, and announced a US$600 million chemistries Center of Excellence in North Carolina. The combination of earnings growth, reaffirmed guidance, and the largest manufacturing investment in the company’s history highlights management’s confidence...
NasdaqGM:HVII
NasdaqGM:HVIICapital Markets

Harrow And 2 Other Growth Stocks Insiders Are Betting On

In the last week, the United States market has remained flat, although it is up 20% over the past year with earnings forecasted to grow by 17% annually. In such a promising environment, growth companies with high insider ownership can be particularly appealing as insiders' confidence in their own firms often signals potential for sustained expansion and value creation.
NasdaqGM:SIGA
NasdaqGM:SIGAPharmaceuticals

Identiv Leads The Charge In These 3 Promising Penny Stocks

Over the last 7 days, the United States market has remained flat, although it is up 20% over the past year, with earnings expected to grow by 17% per annum in the coming years. The term 'penny stocks' might feel like a relic of past market eras, but they continue to represent real potential for investors seeking affordability and growth when backed by strong financials. In this article, we will explore several penny stocks that stand out for their financial strength and potential for...